» Articles » PMID: 17603766

Lack of Association Between MtDNA Haplogroups and Alzheimer's Disease in Tuscany

Overview
Journal Neurol Sci
Specialty Neurology
Date 2007 Jul 3
PMID 17603766
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondrial DNA (mtDNA) haplogroup-specific polymorphisms were previously related to several neurodegenerative diseases, including Alzheimer's disease (AD). However, the precise role of mtDNA haplogroups in the neurodegenerative cascade leading to AD is still unclear. In this work we have genotyped predefined European mtDNA haplogroups in 209 patients with AD and 191 matched controls. In order to minimise the risk of "genetic contamination", which could lead to false associations between gene markers and disease, we were careful to enrol in the study only patients and controls of clear Tuscan origin (with at least three generations of Tuscanborn relatives). The frequency of the haplogroups did not differ between the two groups, and no correlation with gender, ApoE genotype, age of onset or disease status was observed. Further studies will be required to define the contribution of mtDNA haplogroups, if any, to the pathogenesis of AD. A correct population selection, in order to minimise the risk of genetic contamination, is essential in these studies.

Citing Articles

Modeling of mitochondrial genetic polymorphisms reveals induction of heteroplasmy by pleiotropic disease locus 10398A>G.

Smullen M, Olson M, Murray L, Suresh M, Yan G, Dawes P Sci Rep. 2023; 13(1):10405.

PMID: 37369829 PMC: 10300032. DOI: 10.1038/s41598-023-37541-y.


Mitochondrial DNA Repair in Neurodegenerative Diseases and Ageing.

Bazzani V, Equisoain Redin M, McHale J, Perrone L, Vascotto C Int J Mol Sci. 2022; 23(19).

PMID: 36232693 PMC: 9569545. DOI: 10.3390/ijms231911391.


Mitochondrial DNA and Alzheimer's disease: a first case-control study of the Tunisian population.

Ben Salem N, Boussetta S, de Rojas I, Moreno-Grau S, Montrreal L, Mokni N Mol Biol Rep. 2021; 49(3):1687-1700.

PMID: 34854014 DOI: 10.1007/s11033-021-06978-7.


The Role of Mitochondrial Genes in Neurodegenerative Disorders.

Kumar R, Harilal S, Parambi D, Kanthlal S, Rahman M, Alexiou A Curr Neuropharmacol. 2021; 20(5):824-835.

PMID: 34503413 PMC: 9881096. DOI: 10.2174/1570159X19666210908163839.


Exploratory analysis of mtDNA haplogroups in two Alzheimer's longitudinal cohorts.

Swerdlow R, Hui D, Chalise P, Sharma P, Wang X, Andrews S Alzheimers Dement. 2020; 16(8):1164-1172.

PMID: 32543785 PMC: 9847473. DOI: 10.1002/alz.12119.


References
1.
Hardy J, Selkoe D . The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002; 297(5580):353-6. DOI: 10.1126/science.1072994. View

2.
Davis D, Schmitt F, Wekstein D, Markesbery W . Alzheimer neuropathologic alterations in aged cognitively normal subjects. J Neuropathol Exp Neurol. 1999; 58(4):376-88. DOI: 10.1097/00005072-199904000-00008. View

3.
Ghezzi D, Marelli C, Achilli A, Goldwurm S, Pezzoli G, Barone P . Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson's disease in Italians. Eur J Hum Genet. 2005; 13(6):748-52. DOI: 10.1038/sj.ejhg.5201425. View

4.
Swerdlow R, Khan S . A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease. Med Hypotheses. 2004; 63(1):8-20. DOI: 10.1016/j.mehy.2003.12.045. View

5.
Onyango I, Khan S, Miller B, Swerdlow R, Trimmer P, Bennett Jr P . Mitochondrial genomic contribution to mitochondrial dysfunction in Alzheimer's disease. J Alzheimers Dis. 2006; 9(2):183-93. DOI: 10.3233/jad-2006-9210. View